| http://www.w3.org/ns/prov#value | - tezomib and an immunomodulatory agent, such as thalidomide or lenalidomide, and wer...ase 2 clinical trial designed to evaluate response rates based on patients' bortezomib treatment history demonstrated substantial response rates, particularly amo...Keryx Biopharmaceuticals, Inc.
|
